Themis Medicare Share Price
120.42-4.45 (-3.56%)
+16.79% past 1 Year
Themis Medicare Ltd. is a research-based pharmaceutical company specializing in manufacture of a wide range of products for application areas like Pain Management Critical Care and Anti-Infectives. The company develops
Corporate filings & documents
Announcements
Please refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.
2 weeks agoPlease refer to our Intimation of change/updation in Email ID of Company Secretary and RTA.
2 weeks agoNewspaper Publication of Un-audited Financial Results for the quarter ended 30th June 2026
2 weeks agoNewspaper Publication of Un-audited Financial Results for the quarter ended 30th June 2026
2 weeks agoInvestors Presentation for the quarter ended 30.06.2026
3 weeks agoInvestors Presentation for the quarter ended 30.06.2026
3 weeks agoInvestors Presentation for the quarter ended 30.06.2026
3 weeks agoInvestors Presentation for the quarter ended 30.06.2026
3 weeks agoPlease refer to the attachment.
3 weeks agoPlease refer to the attachment.
3 weeks agoPlease refer to the attachment.
3 weeks agoPlease refer to the attachment.
3 weeks agoPlease refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.
3 weeks agoPlease refer to the intimation of appointment of Company Secretary & Compliance Officer and Key Managerial Personnel of the Company.
3 weeks agoKindly refer to the attachment.
3 weeks agoKindly refer to the attachment.
3 weeks agoPlease refer to the outcome of the Board Meeting held on 13th August 2026.
3 weeks agoPlease refer to the outcome of the Board Meeting held on 13th August 2026.
3 weeks agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CTL Trusteeship Ltd
1 month agoThe Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CTL Trusteeship Ltd
1 month agoThemis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter ended on 30th June 2026 and Limited Review Reports of the Statutory Auditors thereon
1 month agoThemis Medicare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 inter alia to consider and approve the Standalone and Consolidated Un-Audited Financial Results for the quarter ended on 30th June 2026 and Limited Review Reports of the Statutory Auditors thereon
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 30 2026 for Vividhmargi Investments Pvt Ltd
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 30 2026 for Vividhmargi Investments Pvt Ltd
1 month agoThe Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 21 2026 for Vividhmargi Trust
1 month agoThe Exchange has received the revised Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 21 2026 for Vividhmargi Trust
1 month agoThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 21 2026 for Vividhmargi Trust
1 month agoThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 21 2026 for Vividhmargi Trust
1 month agoThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 20 2026 for Vividhmargi Investments Pvt Ltd
1 month agoThe Exchange has received revised Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 20 2026 for Vividhmargi Investments Pvt Ltd
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 16 2026 for Vividhmargi Investments Pvt Ltd
1 month agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 16 2026 for Vividhmargi Investments Pvt Ltd
1 month agoPlease refer to the RTA Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018.
1 month agoPlease refer to the RTA Certificate under Reg. 74(5) of SEBI (DP) Regulations 2018.
1 month agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 03 2026 for Vividhmargi Trust
2 months agoThe Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations 2011 on July 03 2026 for Vividhmargi Trust
2 months agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 03 2026 for Vividhmargi Trust
2 months agoThe Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 on July 03 2026 for Vividhmargi Trust
2 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CTL Trusteeship Ltd
2 months agoThe Exchange has received the disclosure under Regulation 10(6) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations 2011 for CTL Trusteeship Ltd
2 months agoIntimation of Closure of Trading Window.
2 months agoIntimation of Closure of Trading Window.
2 months agoPlease refer to the attachment.
2 months agoPlease refer to the attachment.
2 months agoThe Exchange has sought clarification from Themis Medicare Ltd on June 23 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.
2 months agoThe Exchange has sought clarification from Themis Medicare Ltd on June 23 2026 with reference to Movement in Volume.<BR><BR>The reply is awaited.
2 months agoAnnual Secretarial Compliance Report for the financial year ended 31st March 2026
3 months agoAnnual Secretarial Compliance Report for the financial year ended 31st March 2026
3 months agoNewspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026
3 months agoNewspaper Publication of Audited Standalone and Consolidated Financial Results for the quarter and year ended 31.03.2026
3 months agoAnnual reports
Concalls & investor presentations
Aug 2026
ConcallPresentation
May 2026
ConcallPresentation
Feb 2026
ConcallPresentation
Aug 2025
ConcallPresentation
May 2025
ConcallPresentation
Feb 2025
ConcallPresentation
Oct 2024
ConcallPresentation
Jul 2024
ConcallPresentation
May 2024
ConcallPresentation
Feb 2024
ConcallPresentation
Nov 2023
ConcallPresentation
Nov 2023
ConcallPresentation
Aug 2023
ConcallPresentation
May 2023
ConcallPresentation
May 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Feb 2023
ConcallPresentation
Nov 2022
ConcallPresentation
Nov 2022
ConcallPresentation
Corporate Actions
Date
Type
Details
2025-09-04
Dividend
0.5
2024-07-12
Dividend
0.5
2023-10-10
Split
10:1
2023-09-01
Dividend
5.0
2022-09-08
Dividend
5.0
2021-09-08
Dividend
4.3
2020-09-17
Dividend
1.75
2011-07-20
Dividend
3.0
2010-06-16
Dividend
3.0
Company details
Registered office
Plot No 69 A G I D C Industrial Estate Vapi Gujarat PIN: 396195 Tel No: 0260-2431447/ 2430219 Fax No: Email: [email protected] Internet: www.themismedicare.com
Registrars
C 101, 247 Park, LBS Marg, Vikhroli (W), Mumbai(Old Address:) C-13 Pannalal Silk Compound, L B S Marg, Bhandup Mumbai Maharashtra C 101, 247 Park LBS Marg Vikhroli (West) PIN: Tel No: +91 810 811 8484 Fax No: 91-022-49186060 Email: [email protected] Internet: https://in.mpms.mufg.com/
Management
Nagraj Mogaveera, Interim Company Secretary, Compliance Officer & KMP
Dinesh S Patel, Chairman
Sachin D Patel, Managing Director & CEO
Adam Demeter, Non Independent & Non Executive Director, Representative of Foreign Collaborator
Rajneesh Anand, Non Independent & Non Executive Director
Bhaskar V Iyer, Non Executive Independent Director
Shishir Dalal, Non Executive Independent Director
Neha Thakore, Non Executive Independent Director
Nikunt Raval, Non Executive Independent Director
Reena S Patel, Alternate Director
Details
BSE 530199
NSE THEMISMED
ISIN INE083B01024